Trump Secures Drug Price Cuts, Targets Insurance Companies Next

President Trump has announced new agreements with nine major pharmaceutical companies. The deals require them to sell certain prescription drugs at lower prices. The discounts apply to medicines sold to the government's Medicaid program and directly to consumers. These companies are the latest to agree to such terms under the administration's pricing initiative. In a statement, President Trump said the move would reduce costs for many Americans. He also revealed the next phase of his plan. The administration will soon start similar negotiations with private health insurance companies. The goal is to extend discounted drug pricing to more people covered by private plans. This effort is part of a broader push to lower prescription drug costs in the United States.